Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

October 09, 2015 2:44 AM ET


Company Overview of Arysta LifeScience Corporation

Company Overview

Arysta LifeScience Corporation develops, markets, and distributes agrochemical solutions. The company offers insecticides, fungicides, herbicides, biostimulants, and value-added nutrients. It offers animal health products for minor species, companion animals, and livestock, including anti-mite treatment for honey bees; cosmetic and pharmaceutical active ingredients and additives, as well as excipients for pharmaceutical and food additive industries; and controlled release fertilizers for the horticulture. The company serves agroscience, and health and nutrition science customers, including wholesalers, retailers, cooperatives, and farmers. It offers its products through sales and marketing r...

38th Floor

St Luke's Tower

8-1, Akashi-cho


Tokyo,  104-6591


Founded in 2001


81 3 3547 4500


81 3 3547 4699

Key Executives for Arysta LifeScience Corporation

Chief Financial Officer and Representative Director
Age: 50
Chief Executive Officer of Göemar
Age: 59
Chief Operating Officer of Agrochemical Segment
Age: 62
Head of Africa and Western Europe Business Unit
Age: 53
Head of Japan & Central/Eastern Europe Business Unit
Age: 46
Compensation as of Fiscal Year 2015.

Arysta LifeScience Corporation Key Developments

Arysta Lifescience Corporation Appoints David Jones as a Non- Executive Chairman

Arysta Lifescience Corporation appointed David Jones as a Non- Executive Chairman.

Platform To Raise Funds For Arysta

Platform Specialty Products Corporation (NYSE:PAH) intends to raise funds to help finance a large portion of its planned $3.5 billion acquisition of Arysta LifeScience Corporation. Platform said that it would offer $500 million of senior notes due 2022 and a 350 million of senior notes, also due 2022, in a private offering, subject to market and other customary conditions.

Platform Specialty Products Reportedly In Advanced Talks To Buy Arysta

Platform Specialty Products Corporation (NYSE:PAH) is in advanced talks to acquire Arysta LifeScience Corporation from Permira Advisers Ltd., people familiar with the matter said. A deal that could value Arysta LifeScience Corporation at $3.5 billion, including debt, could come as soon as this month, the people said, cautioning that Permira may decide not to sell the company to Platform Specialty Products and opt to take it public instead. The sources asked not to be identified because the discussions are private. Permira Advisers Ltd. declined to comment, while a representative for Arysta LifeScience Corporation did not immediately respond to a request for comment.

Similar Private Companies By Industry

Company Name Region
DuPont Asia Pacific, Ltd. Asia
MT AquaPolymer, Inc. Asia
Tateho Chemical Industries Co., Ltd. Asia
UMG ABS, Ltd. Asia
Sojitz Pla-Net Corporation Asia

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Arysta LifeScience Corporation, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at